oasis-1 oral semaglutide 50 mg obesity nejm 2023 taken once per day in adults with overweight or (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial Most viewed this week from – 🥼🧪Slide Deck: Efficacy and safety

They will come in handy when throwing a quick, nutritious meal for you and your family

Resources We Trust Mayo Clinic: Alcohol Use Disorder: Diagnosis & Treatment Cleveland Clinic: GLP-1 Agonists National Institute on Alcohol Abuse and Alcoholism: Understanding Alcohol Use Disorder American Psychiatric Association: Alcohol Use Disorder MedlinePlus: Alcohol Use Disorder (AUD) Brunchmann A et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 228.Chio I.I.C., Tuveson D.A

Dosing schedules compared Both drugs use once-weekly subcutaneous injection with gradual dose titration

Arora G, Mannalithara A, Mithal A, Triadafilopoulos G, Singh G

Recommendation #3